News

Under the deal, Moberg Pharma has been granted Menarini Asia-Pacific the exclusive rights to market and sell Kerasal Nail in eight Southeast Asian countries. The deal builds on

The manufacturing plant was previously approved by the European Medicines Agency (EMA) for production of VPRIV drug substance. National Gaucher Foundation CEO and executive director Rhonda Buyers said,

Ben Venue Laboratories has initiated this voluntary recall on 14 February 2014 and has informed the US Food and Drug Administration (FDA) of its actions. The company is

The acquisition is part of Medifirst Solutions plan to increase its internal technology infrastructure and add technical and digital services and expertise to its internal business operations. Medifirst

Forest has notified the US Food and Drug Administration of this decision. The oral solution of NAMENDA and once-daily NAMENDA XR (memantine HCl) extended-release capsules will continue to

The technology is being announced during the Advances in Genome Biology & Technology (AGBT) conference, which is recognized throughout the sequencing community as a cornerstone for the discussion

The 10 lots were manufactured by Agila Specialties Polska in Warsaw, Poland. All of the products bear a Pfizer label. Agila Specialties initiated the recall on 13 February

The opinion will be subject to review by the EC, which finally grants the decision on orphan drug designation. ATTR-Amyloidosis or TTR amyloidosis is a severe and rare

EGPA, which can be life-threatening for some patients, is previously known as Churg-Strauss syndrome and it is a rare disease which is characterized by widespread inflammation in the